2022 Annual Meeting Paper Presentations

Click on the title of each Paper to view the Paper Abstract. 

Paper #  Title of Paper  Name of Presenter 
1 The prognostic importance of pathologic fracture in limb salvage surgery for primary bone sarcoma of the extremities  Joseph Kendal, MD, FRCSC
2 Surgical staging of osteosarcoma: does incorporation of chemotherapy response improve prediction of local recurrence?  Zachary Burke, MD
3 Biologic reconstruction with distraction osteogenesis in osseous sarcomas: A prospective analysis  Anthony Bozzo, MD
4 Reverse total shoulder arthroplasty demonstrates improved functional outcomes over hemiarthroplasty following proximal humerus replacement: long-term results of 170 cemented endoprosthetic reconstructions for tumors of the upper extremity  Lauren E. Wessel, MD 
5 Should larger stem diameter be prioritized over cement mantle thickness? An analysis of risks for failure in cemented endoprostheses with minimum five-year  Joseph Ippolito, MD 
How do the outcomes of radiation associated pelvic and sacral bone sarcomas compare to primary osteosarcomas following surgical resection?  Alexander Leandros Lazarides, MD
The Use of Deep Learning for Necrosis Assessment in Patients with Osteosarcoma  Christa L. LiBrizzi, MD
Bone marrow aspiration and biopsy in the initial staging of extraskeletal Ewing sarcoma  Brian Wahlig
Serum Metal Ion Concentrations in the Setting of an Oncologic Endoprosthesis: Is There Cause for Concern?  Matthew T. Houdek, MD 
10 Surgical Management of Chondrosarcoma of long bones utilizing a pre-operative radiologic aggressiveness score?  Zachary Burke, MD
11  Usage Trends and Safety Profile of Recombinant Human Bone Morphogenetic Protein-2 for Spinal Column Tumor Surgery: A National Matched Cohort Analysis  Noe C. Trevino
12  Re-evaluating the Work Up of Bone Lesions of Unknown Etiology: A Systematic Analysis  Harrison Miner, MD
13  Functional Outcomes of Pediatric and Adult Patients after Endoprosthetic Reconstruction of Lower Extremity Tumors  Tina H. Tran, BS
14  Mapping The Course of Recovery Following Limb Salvage Surgery for Soft Tissue Sarcoma of the Extremities  Alexander Leondros Lazarides, MD
15  The Sarcoma-Specific Quality of Life Study (SARC-QoL): Identifying key domains of Health-Related Quality of Life in adult patients with extremity soft tissue sarcoma  Krista Goulding MD, FRCSC, MPH
16  Utilization of Mental Health Referrals for Symptoms of Anxiety and Depression in Patients with Sarcoma  Meredith Bartelstein, MD
17  Targeting immune checkpoint blockade molecule B7-H3 using CAR T cells as adjuvant therapy in chordoma  David Osei-Hwedieh, MD, PhD
18  SKP2 knockout in Rb1/p53 deficient transgenic mouse models of osteosarcoma improves survival via induction of macrophage infiltration  Alexander Ferrena
19  DNMT3B is a novel target in high grade chondrosarcoma  Alex Michael Hollenberg
20  Expression of Angiogenesis Markers HSP70, HSP90, VEGF and pERK1/2 in Both Components of Dedifferentiated Chondrosarcomas  Rebekah Belayneh, MD
21  Intra-Articular Injections of AMB-05X, A Potent, Selective, Human Monoclonal Antibody Against Colony Stimulating Factor 1 Receptor for the Treatment of Tenosynovial Giant Cell Tumor  Thomas J. Scharschmidt, MD
22 Use of Small Molecule STING Agonist Immunotherapy for Canine Soft Tissue Sarcoma: A Cross-Species Analysis  Michael Monument, MD
23 Improvement in Survival After Treatment for Metastatic Bone Disease: An International Trend-Analysis  Davis Lane Rogers, MD
24 Indications and longevity of endoprosthetic reconstructions for patients with metastatic bone disease  Joseph Kendal, MD, FRCSC
25 Effectiveness of immune checkpoint inhibitor therapy on bone metastases in non-small-cell lung cancer  Michael Monument, MD
26 Locking Plate Augmentation of Polymethylmethacrylate-Filled Distal Femur Defects  Harrison Robert Ferlauto, MD
27 Comparison of Carbon Fiber and Titanium Intramedullary Nails In Orthopaedic Oncology  Santiago Lozano-Calderon, MD,   PhD
28 The Musculoskeletal Tumor Registry: Progress and Priorities Update for 2022  Adam S. Levin, MD
29 Development Of The Metastatic Bone Disease Module Within The American Academy Of Orthopaedic Surgeons Musculoskeletal Tumor Registry  George T. Calvert, MD
30 Establishing Data Elements for the Musculoskeletal Tumor Registry Sarcoma Module  Adam S. Levin, MD
31 Minimally Invasive Percutaneous Screw Fixation in Painful Pelvic Lesion Caused by Metastatic Cancer  Rui Yang, MD
32 Treatment of oligometastases: indications and results in 156 cases  Pietro Ruggieri, MD
33 Metastatic Bone Disease at Diagnosis is Associated with Increased Rate of Body Mass Index Loss and Worse Survival in Clear Cell Renal Cell Carcinoma  Jon-Luc Poirier, BA
34  Clinical Outcomes of Patients Treated with Carbon-Fiber Nails for Oncologic Indications in Long-Bones: An International Multi-Institutional Study  Santiago A. Lozano-Calderon, MD,   PhD
35 A cost effectiveness analysis of elective versus emergent surgery for patients with metastatic bone disease  Joseph Kendal, MD, FRCSC
36 Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: Final results from the phase 3 ENLIVEN study  John H. Healey, MD, FACS
37 Defining minimally important differences in functional outcomes for musculoskeletal oncology patients undergoing lower extremity endoprosthetic reconstruction  Aaron M. Gazendam, MD
38 Predictors of functional recovery among musculoskeletal oncology patients undergoing lower extremity endoprosthetic reconstruction  Aaron M. Gazendam, MD
39 Neoadjuvant chemotherapy and endoprosthetic reconstruction for lower extremity sarcomas: Does timing impact complication rates?  Aaron M. Gazendam, MD
40 Opioid use in musculoskeletal oncology  Aaron M. Gazendam, MD
41 Risk factors for all-cause early re-operations in patients undergoing tumor resection and endoprosthetic reconstruction: a secondary analysis from the PARITY trial  Joseph Kendal, MD, FRCSC
42 Surveillance AFter Extremity Tumor surgerY (SAFETY): Results of the Pilot International Randomized Controlled Trial  Michelle Ghert, MD, FRCSC
43 Gender Disparity within the Musculoskeletal Tumor Society: Does it exist?  Brian Batko, MD
44 Epidemiology And Survival Factors For Sarcoma Patients In Minority Populations: A Seer-Retrospective Study  Victoria Dahl
45 The Work Relative Value Unit System May Not Be the Optimal Measure of an Orthopaedic Oncologist's Productivity  Tae Won Benjamin Kim, MD
46 Using the Social Vulnerability Index to Assess Social Determinants of Bone Cancer Care & Prognosis in the United States  David Fei-Zhang, BA
47 Patient engagement in sarcoma research: benefits, challenges, importance, and implications  Michelle Ghert, MD, FRCSC
48 MRI based navigated cryosurgery of extra-abdominal desmoid tumors using skin fiducials markers  Ortal Segal, MD

49 Development of a Prognostic Nomogram to Predict 30-day Readmission in Localized Soft Tissue Sarcomas of the Extremity  Meena Bedi, MD
50 Outcome of Multidisciplinary Treatment of Merkel Cell Carcinoma of the Lower Extremity  Samuel E. Broida, MD
51 Predicting Diagnosis in Myxoid Soft Tissue Tumors: Performance of Radiomics vs. Radiologists  Joshua M. Lawrenz, MD
52 First-in-human Clinical Trial Results of a Small-Molecule Fluorophore Applied to Soft-Tissue Sarcomas  Eric R Henderson, MD
53 Clinical impact of whole-body MRI in the staging and surveillance of patients with myxoid liposarcoma: a 14-year single-center experience  Robert Turcotte, MD
54 MSTS Member Survey: Intra-Operative Peripheral Margins in Soft Tissue Sarcoma  Lauren Zeitlinger, DO
55 Do High- and Low-Risk Pediatric Rhabdomyosarcoma Survival Estimates Equalize 5 Years After Diagnosis? A Cause-specific Conditional Survival Analysis  Benjamin J. Miller, MD, MS
56 What factors differentiate early vs. late pulmonary metastases in soft tissue sarcoma of the extremities? A comparative cohort analysis  Alexander Leandros Lazarides, MD
57 Follow-up for patients with extremity soft tissue sarcoma: validation of a rational schedule.  Maroun Rizkallah, MD